Capital Impact Advisors’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-26,076
| Closed | -$129K | – | 176 |
|
|
2023
Q1 | $129K | Buy |
26,076
+9,175
| +54% | +$45.3K | 0.16% | 166 |
|
|
2022
Q4 | $106K | Sell |
16,901
-2,638
| -14% | -$16.6K | 0.1% | 220 |
|
|
2022
Q3 | $196K | Buy |
19,539
+3,839
| +24% | +$38.5K | 0.2% | 183 |
|
|
2022
Q2 | $179K | Buy |
+15,700
| New | +$179K | 0.17% | 205 |
|
|
2021
Q1 | – | Sell |
-41,800
| Closed | -$1.06M | – | 110 |
|
|
2020
Q4 | $1.06M | Sell |
41,800
-85,396
| -67% | -$2.16M | 0.26% | 98 |
|
|
2020
Q3 | $4.8M | Buy |
127,196
+90,000
| +242% | +$3.39M | 1.42% | 14 |
|
|
2020
Q2 | $1.59M | Sell |
37,196
-41,336
| -53% | -$1.77M | 0.53% | 88 |
|
|
2020
Q1 | $1.53M | Buy |
78,532
+3,114
| +4% | +$60.6K | 0.64% | 74 |
|
|
2019
Q4 | $1.96M | Hold |
75,418
| – | – | 0.69% | 83 |
|
|
2019
Q3 | $2.06M | Buy |
75,418
+10,756
| +17% | +$293K | 0.78% | 50 |
|
|
2019
Q2 | $1.72M | Buy |
+64,662
| New | +$1.72M | 0.63% | 87 |
|